Hoth Therapeutics, Inc. (HOTH)
NASDAQ: HOTH · Real-Time Price · USD
0.734
-0.046 (-5.86%)
At close: Apr 28, 2026, 4:00 PM EDT
0.751
+0.017 (2.30%)
After-hours: Apr 28, 2026, 5:27 PM EDT
Hoth Therapeutics Employees
As of December 31, 2025, Hoth Therapeutics had 3 total employees, including 2 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$4,156,434
Market Cap
14.05M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Citius Pharmaceuticals | 23 |
| BioCardia | 21 |
| Moleculin Biotech | 17 |
| SeaStar Medical Holding | 17 |
| Intensity Therapeutics | 7 |
| Phio Pharmaceuticals | 6 |
| Jupiter Neurosciences | 5 |
| Kairos Pharma | 4 |
HOTH News
- 14 days ago - Move Over Novo Nordisk - This Small Company Study Flags Edge In Fatty Liver Drug - Benzinga
- 14 days ago - Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide - PRNewsWire
- 26 days ago - Hoth Therapeutics Announces Closing of $2.0 Million Registered Direct Offering - PRNewsWire
- 27 days ago - Hoth Therapeutics Announces $2.0 Million Registered Direct Offering - PRNewsWire
- 27 days ago - Hungary Approves Trial Expansion as HT-001 Meets Primary Endpoint in Interim Analysis with Patients Reaching ARIGA ≤1 by Week Six - PRNewsWire
- 4 weeks ago - Hoth Therapeutics Announces Issuance of Chinese Patent for Cancer Cell-Targeting Technology - PRNewsWire
- 4 weeks ago - Hoth Therapeutics Deploys OpenClaw™ AI Platform to Accelerate Drug Discovery - PRNewsWire
- 5 weeks ago - Hoth Therapeutics Reports Positive HT-001 PK, Safety, and Clinical Activity Data in Cancer Patients with EGFR Therapy-Associated Skin Toxicities Showing ~77% Increase in Drug Exposure and Minimal Systemic Absorption - PRNewsWire